semaglutide vs semaglutide compound for weight loss | Blog Compounded Semaglutide - Green Relief

From hormone optimization and GLP-1 weight loss to root-cause functional medicine, we treat what standard care misses

Current evidence primarily supports associations rather than causality, and predictive microbial signatures require validation in independent, large-scale cohorts before guiding therapy selection

This reflects a broader access problem that disproportionately affects lupus patients because their indication for these medications (managing corticosteroid-induced weight gain and reducing cardiovascular risk in an autoimmune condition) does not fit neatly into approved indication categories

I suppose time will tell

For example, Zepbound may interact with oral contraceptives or diabetic drugs

Legitimate access is limited to participation in authorised clinical trials or, if granted, MHRA early access mechanisms such as the Early Access to Medicines Scheme (EAMS) neither of which has been announced for retatrutide at this time